22 results
8-K
EX-1.1
6v8hik22cp2s9rl0np8o
8 Dec 20
Arcturus Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock
9:01am
8-K
EX-1.1
g6b7y
29 Jul 20
Arcturus Therapeutics Announces Pricing of $173.0 Million Public Offering of Common Stock
6:02am
8-K
EX-1.1
82uem6ohjfrijl
17 Apr 20
Entry into a Material Definitive Agreement
6:06am
8-K
EX-10.1
dhr05is2jilfq
27 Mar 20
Entry into a Material Definitive Agreement
5:20pm
10-K
xfni5390 w27
16 Mar 20
Annual report
11:09am
8-K
EX-10.1
pxo gkmreo
27 Sep 19
Arcturus Therapeutics Announces $9.8 Million Registered Direct Offering of Common Stock
4:25pm
8-K
EX-10.1
if5paxisk hyi2dby
5 Aug 19
Arcturus Therapeutics Announces $2.3 Million Additional Registered Direct Offering of Common Stock
9:14am
8-K
EX-10.1
7ka agevoayz1eu1a
2 Aug 19
Arcturus Therapeutics Announces $10.9 Million Registered Direct Offering of Common Stock
4:29pm
8-K
EX-4.1
0qbbkkbdnhkp4f
20 Jun 19
License Agreement to Develop Additional Nucleic Acid Therapies for Rare Diseases
6:06am
424B3
mwzdbcuq8ybv j4k9
12 Apr 19
Prospectus supplement
4:39pm